AtriCure Inc
NASDAQ:ATRC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AtriCure Inc
NASDAQ:ATRC
|
US |
|
M
|
Mandarin Oriental International Ltd
LSE:MDOB
|
HK |
|
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
US |
|
Lockheed Martin Corp
NYSE:LMT
|
US |
|
K
|
Knight-Swift Transportation Holdings Inc
F:KSX
|
US |
|
AVITA Medical Inc
NASDAQ:RCEL
|
US |
|
H
|
Heartland Group Holdings Ltd
F:73X
|
NZ |
|
Assa Abloy AB
F:ALZC
|
SE |
|
A
|
Atlantic Sapphire ASA
DUS:4AS
|
NO |
Wall St Price Targets
ATRC Price Targets Summary
AtriCure Inc
According to Wall Street analysts, the average 1-year price target for
ATRC is 50.36 USD with a low forecast of 43.43 USD and a high forecast of 57.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ATRC's stock price target?
Price Target
50.36
USD
According to Wall Street analysts, the average 1-year price target for
ATRC is 50.36 USD with a low forecast of 43.43 USD and a high forecast of 57.75 USD.
What is the Revenue forecast for AtriCure Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 6 years is 14%.
What is the Gross Profit forecast for AtriCure Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 6 years is 14%.